missing translation for 'onlineSavingsMsg'
Learn More
Learn More
p21/CIP1/CDKN1A Antibody (CIP1/823 + DCS-60.2) - Azide and BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
591.00€
Specifications
| Antigen | p21/CIP1/CDKN1A |
|---|---|
| Clone | CIP1/823 + DCS-60.2 |
| Concentration | 1.0 mg/mL |
| Dilution | Flow Cytometry : 0.5 - 1 ug/million cells in 0.1 ml, Immunohistochemistry-Paraffin : 2 - 4 ug/ml, Immunofluorescence : 1 - 2 ug/ml, CyTOF-ready |
| Applications | Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence, CyTOF |
Description
p21/CIP1/CDKN1A Monoclonal specifically detects p21/CIP1/CDKN1A in Human, Mouse (Negative), Rat (Negative) samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin.Specifications
| p21/CIP1/CDKN1A | |
| 1.0 mg/mL | |
| Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence, CyTOF | |
| Unconjugated | |
| Mouse | |
| Apoptosis, Breast Cancer, Cancer, Cell Cycle and Replication, DNA Repair | |
| PBS with No Preservative | |
| 1026 | |
| Recombinant full-length human CDKN1A protein (CIP1/823); Human recombinant p21 protein (DCS-60.2) | |
| Primary | |
| Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
| 21 kDa |
| CIP1/823 + DCS-60.2 | |
| Flow Cytometry : 0.5 - 1 ug/million cells in 0.1 ml, Immunohistochemistry-Paraffin : 2 - 4 ug/ml, Immunofluorescence : 1 - 2 ug/ml, CyTOF-ready | |
| Monoclonal | |
| Purified | |
| RUO | |
| Human, Mouse (Negative), Rat (Negative) | |
| CAP20cyclin-dependent kinase inhibitor 1, CDK-interacting protein 1, CDKN1melanoma differentiation associated protein 6, CIP1WAF1CDK-interaction protein 1, cyclin-dependent kinase inhibitor 1A (p21, Cip1), MDA6, MDA-6, Melanoma differentiation-associated protein 6, p21, p21CIP1, p21Cip1/Waf1, PIC1, SDI1DNA synthesis inhibitor, wild-type p53-activated fragment 1 | |
| CDKN1A | |
| IgG | |
| Protein A or G purified | |
| This MAb recognizes a 21kDa protein, identified as the p21WAF1 tumor suppressor protein. This MAb is highly specific to p21 and shows no cross-reaction with other closely related mitotic inhibitors. p21WAF1 is a specific inhibitor of cdk s and a tumor suppressor involved in the pathogenesis of a variety of malignancies. The expression of this gene acts as an inhibitor of the cell cycle during G1 phase and is tightly controlled by the tumor suppressor protein p53. Its expression is induced by the wild type, but not mutant, p53 suppressor protein. Normal cells generally display a rather intense nuclear p21 expression. Loss of p21 expression has been reported in many carcinomas (gastric carcinoma, non-small cell lung carcinoma, thyroid carcinoma). |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title